LDS/Medical Tests/Apolipoprotein B (APOB) Mutation Detection

Apolipoprotein B (APOB) Mutation Detection

Apolipoprotein B-100 is a protein synthesized in the liver that will bind to the surface of LDL (low density lipoprotein), and is responsible for carrying cholesterol to the organs and tissues. LDL is known as the “bad cholesterol” and when it is present in large amounts, it will cause excess cholesterol build-up in the arteries of the heart or other major organs causing atherosclerosis. Apolipoprotein B-100 is a more sensitive test for heart disease than LDL or total cholesterol and may become a standard lipid test in the future. Apolipoprotein B levels increase in pregnancy, hypercholesterolemia, and kidney damage (nephrotic syndrome).

Mutations in the APOB gene can cause hypobetalipoproteinemia, a genetic disorder that presents with low LDL and APOB. Patients who are homozygous for the APOB gene mutation will have low cholesterol levels early in life. Progressive neurologic damage will result as the patient gets older. Heterozygotes are asymptomatic, but have low LDL levels, which may result in decreased risk of heart disease. Apolipoprotein B100 assays usually involve the addition of antibodies to APOB and the detection of the antigen/antibody complexes. Genetic tests are also available to test for the familial disorders. Apolipoprotein B is tested to aid physicians in the diagnosis of abnormal lipid metabolism, hypobetalipoproteinemia, coronary heart disease, and to monitor treatment of lipid disorders.

  • Evaluation of risk for coronary heart disease when used in conjuction with Apo A-1
  • As an aid in diagnosis of abetalipoproteinemia and hypobetalipoproteinemia
  • Aid in the diagnosis of abnormal lipid metabolism
  • Monitor for lipid therapy
  • Secondary testing when LDL levels are increased
  • Identifying patients with normal LDL cholesterol who have increased number of LDL particles and are at increased risk of heart disease

Increased in:

  • Lipid metabolism disorders
  • Hyperapobetalipoproteinemia
  • High LDL levels
  • Familial combined hyperlipidemia
  • Familial hypercholesterolemia
  • Familial defective Apo B-100
  • Pregnancy
  • High cholesterol levels
  • Hypothyroidism
  • Cushing's syndrome
  • Liver disease
  • Renal failure/ Proteinuria/ Nephrotic syndrome

Decreased in:

  • Lipid metabolism disorders
  • Hypobetalipoproteinemia
  • Abetalipoproteinemia
  • Severe infection/ Sepsis
  • Inflammation
  • Estrogen therapy
  • Hyperthyroidism
  • Intestinal malabsorption
  • Malnutrition

Complete lipid profile that included direct LDL and VLDL should be ordered with AboB. As ApoB is directly measured and represents a direct evaluation of the amount of cholesterol present since one particle of ApoB contains one particle of cholesterol, ApoB measurements correlate better with the incidence of cardiac artery calcifications than do LDL values.

Men: 66-133 mg/dL
Women: 60-117 mg/dL
 

 

 

Immunoturbidimetric

Serum (SST) or Plasma EDTA (Lavender), Heparin (Green)

Stability

  • Ambient: 72 hours
  • Refrigerated: 10 days
  • Frozen: 90 days
  • Avoid repeated freezing and thawing.
Lipid profile, liver panel, Apolipoprotein A-I, Apolipoprotein E, renal panel, lipid fractionation, lipoprotein metabolism profile, APOB genetic mutation analysis, blood cultures.
1 day after receipt in performing laboratory days
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Diabetes. 2009 Aug;58(8):1887-92. Epub 2009 Jun 2. [PMID: 19491209] Circulation. 1990 Nov;82(5):1574-94. [PMID: 1977530]
  • QJM. 2006 May;99(5):277-87. [PMID: 16504986]
  • Adv Exp Med Biol. 1991;285:25-31. [PMID: 1858554]
  • Clin Chem. 1989 Jul;35(7):1357-61. [PMID: 2503261]
  • Scand J Clin Lab Invest Suppl. 1990;198:58-65. [PMID: 2111937]
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757